Highlights of the 56th annual scientific session of the American College of Cardiology.
Rabasseda
X
X
Prous Science Medical Information Department, Prous Science.
D000925:Anticoagulants / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000628:therapy*; D048909:Diabetes Complications; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D006973:Hypertension / Q000150:complications; D024821:Metabolic Syndrome / Q000150:complications; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D015607:Stents
D000925:Anticoagulants; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors